Northwestern Mutual Wealth Management Co. Raises Stock Position in Alignment Healthcare, Inc. $ALHC

Northwestern Mutual Wealth Management Co. raised its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 7,684,933.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 691,653 shares of the company’s stock after buying an additional 691,644 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Alignment Healthcare were worth $13,660,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in Alignment Healthcare by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after buying an additional 1,524,218 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Alignment Healthcare by 167.3% in the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after purchasing an additional 6,940,277 shares during the last quarter. 8 Knots Management LLC lifted its stake in shares of Alignment Healthcare by 6.4% during the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after buying an additional 300,409 shares during the period. Invesco Ltd. lifted its stake in shares of Alignment Healthcare by 7.1% during the third quarter. Invesco Ltd. now owns 4,466,630 shares of the company’s stock valued at $77,943,000 after buying an additional 296,101 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of Alignment Healthcare by 8.4% during the fourth quarter. Geode Capital Management LLC now owns 3,841,703 shares of the company’s stock valued at $75,884,000 after buying an additional 299,279 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Christopher J. Joyce sold 18,013 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $17.79, for a total value of $320,451.27. Following the completion of the sale, the insider owned 305,451 shares of the company’s stock, valued at $5,433,973.29. This represents a 5.57% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $16.09, for a total value of $482,700.00. Following the completion of the sale, the president directly owned 998,813 shares of the company’s stock, valued at $16,070,901.17. The trade was a 2.92% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,569,859 shares of company stock valued at $29,433,158. 5.20% of the stock is owned by insiders.

Alignment Healthcare Stock Performance

Shares of NASDAQ:ALHC opened at $13.30 on Tuesday. The firm has a market capitalization of $2.75 billion, a PE ratio of 147.78, a P/E/G ratio of 2.15 and a beta of 1.14. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. The business has a 50-day moving average of $18.57 and a two-hundred day moving average of $19.38. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. During the same period in the prior year, the firm posted ($0.05) earnings per share. The firm’s revenue was up 33.3% on a year-over-year basis. As a group, research analysts forecast that Alignment Healthcare, Inc. will post 0.19 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ALHC shares. UBS Group upped their price objective on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a research note on Thursday, May 7th. Finally, Barclays reduced their price objective on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.30.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.